Open Access

[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

  • Authors:
    • Qingfu Deng
    • Li Luo
    • Zhen Quan
    • Nanjing Liu
    • Zhongbo Du
    • Wei Sun
    • Chunli Luo
    • Xiaohou Wu
  • View Affiliations

  • Published online on: May 23, 2022     https://doi.org/10.3892/mmr.2022.12746
  • Article Number: 230
  • Copyright : © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

July-2022
Volume 26 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Deng Q, Luo L, Quan Z, Liu N, Du Z, Sun W, Luo C and Wu X: [Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain. Mol Med Rep 26: 230, 2022
APA
Deng, Q., Luo, L., Quan, Z., Liu, N., Du, Z., Sun, W. ... Wu, X. (2022). [Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain. Molecular Medicine Reports, 26, 230. https://doi.org/10.3892/mmr.2022.12746
MLA
Deng, Q., Luo, L., Quan, Z., Liu, N., Du, Z., Sun, W., Luo, C., Wu, X."[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain". Molecular Medicine Reports 26.1 (2022): 230.
Chicago
Deng, Q., Luo, L., Quan, Z., Liu, N., Du, Z., Sun, W., Luo, C., Wu, X."[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain". Molecular Medicine Reports 26, no. 1 (2022): 230. https://doi.org/10.3892/mmr.2022.12746